INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of REGENXBIO Inc. - RGNXGlobeNewsWire • 02/03/26
Lost Money on REGENXBIO Inc. (RGNX)? Possible Fraud - Contact Levi & Korsinsky TodayNewsfile Corp • 02/02/26
Regenxbio (RGNX) Soars 5.4%: Is Further Upside Left in the Stock?Zacks Investment Research • 01/30/26
Investigation into Regenxbio: Questions Arise Over Disclosure Completeness Prior to FDA ActionPRNewsWire • 01/29/26
RGNX ALERT: Levi & Korsinsky Investigates REGENXBIO Inc. for Possible Securities Fraud ViolationsNewsfile Corp • 01/29/26
INVESTOR ALERT: Investigation of REGENXBIO Inc. (RGNX) by Holzer & Holzer, LLCGlobeNewsWire • 01/28/26
The 'Confusing And Unexpected' Update That Slammed Regenxbio StockInvestors Business Daily • 01/28/26
REGENXBIO Inc. (RGNX) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/14/26
REGENXBIO Highlights Key 2026 Catalysts and Announces Positive Long-Term Functional Outcomes in Lead Duchenne Gene Therapy ProgramPRNewsWire • 01/11/26
REGENXBIO Reports Third Quarter 2025 Financial Results and Operational HighlightsPRNewsWire • 11/06/25
REGENXBIO Announces Completion of Pivotal Enrollment and Initiates Commercial Production in Duchenne Gene Therapy ProgramPRNewsWire • 10/30/25
REGENXBIO to Host Conference Call on November 6 to Discuss Third Quarter 2025 Financial Results and Operational HighlightsPRNewsWire • 10/29/25
REGENXBIO Announces Presentation at the American Academy of Ophthalmology 2025 Annual MeetingPRNewsWire • 10/09/25
REGENXBIO Announces Completion of Enrollment in Pivotal Trials of Subretinal Surabgene Lomparvovec for Wet AMDPRNewsWire • 10/06/25
Regenxbio: Poised For Breakthrough With RGX-121 Gene Therapy In Hunter SyndromeSeeking Alpha • 09/09/25
REGENXBIO Inc. (RGNX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/08/25